CorMedix (CRMD) Gross Margin (2013 - 2025)

CorMedix (CRMD) reported Gross Margin of 83.43% for Q4 2025, down 1280.0% on a YoY basis from 7.07% in Q4 2024, and down 6.53% sequentially from 89.26% in Q3 2025.

CorMedix (CRMD) Gross Margin (2013 - 2025) Analysis & Trends

CorMedix (CRMD) has 12 years of Gross Margin data on file, last reported at 83.43% in Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 1280.0% year-over-year to 83.43%; the trailing twelve-month figure through Dec 2025 stood at 88.46% (down 414.0% YoY), and the FY2025 full-year result was 88.46%, down 420.0% from the prior year.
  • Gross Margin retreated to 83.43% in Q4 2025, from 89.26% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 98.63% in Q4 2022 to a low of 76.12% in Q2 2021.
  • A 4-year average of 63.31% and a median of 83.43% in 2025 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin sank 5945 bps in 2021 and soared 17456 bps in 2022, its largest moves.
  • Tracing CRMD's Gross Margin over 4 years: stood at 14.88% in 2021, then surged by 563 bps to 98.63% in 2022, then slipped by 2 bps to 96.24% in 2024, then fell by 13 bps to 83.43% in 2025.
  • Business Quant data shows CRMD's Gross Margin at 83.43% in Q4 2025, 89.26% in Q3 2025, and 95.31% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn 83.43%

Historic Data

Download Data
DateValue
Dec 31, 2025 83.43%
Sep 30, 2025 89.26%
Jun 30, 2025 95.31%
Mar 31, 2025 95.91%
Dec 31, 2024 96.24%
Sep 30, 2024 94.01%
Jun 30, 2024 36.75%
Dec 31, 2022 98.63%
Sep 30, 2022 78.45%
Jun 30, 2022 98.44%
Mar 31, 2022 80.00%
Dec 31, 2021 14.88%
Sep 30, 2021 33.93%
Jun 30, 2021 -76.12%
Mar 31, 2021 30.50%
Dec 31, 2020 -2.72%
Sep 30, 2020 14.09%
Jun 30, 2020 -16.67%
Mar 31, 2020 34.48%
Dec 31, 2019 -86.15%